These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 37957623)

  • 1. Liquid-based biomarkers in breast cancer: looking beyond the blood.
    Shuai Y; Ma Z; Ju J; Wei T; Gao S; Kang Y; Yang Z; Wang X; Yue J; Yuan P
    J Transl Med; 2023 Nov; 21(1):809. PubMed ID: 37957623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer.
    Freitas AJA; Causin RL; Varuzza MB; Calfa S; Hidalgo Filho CMT; Komoto TT; Souza CP; Marques MMC
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumour DNA - looking beyond the blood.
    Tivey A; Church M; Rothwell D; Dive C; Cook N
    Nat Rev Clin Oncol; 2022 Sep; 19(9):600-612. PubMed ID: 35915225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy in breast cancer: A comprehensive review.
    Alimirzaie S; Bagherzadeh M; Akbari MR
    Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid Biopsy in Bladder Cancer.
    Cui Y; Cao M
    Methods Mol Biol; 2023; 2695():111-120. PubMed ID: 37450114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes.
    Nimir M; Ma Y; Jeffreys SA; Opperman T; Young F; Khan T; Ding P; Chua W; Balakrishnar B; Cooper A; De Souza P; Becker TM
    Cells; 2019 Jul; 8(7):. PubMed ID: 31288377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management.
    Fici P
    Methods Mol Biol; 2019; 1909():47-73. PubMed ID: 30580422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring.
    Alemzadeh E; Allahqoli L; Dehghan H; Mazidimoradi A; Ghasempour A; Salehiniya H
    Oncol Res; 2023; 31(5):667-675. PubMed ID: 37547763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of cancer patients via next-generation sequencing of patient-derived circulating tumor cells and tumor DNA.
    Onidani K; Shoji H; Kakizaki T; Yoshimoto S; Okaya S; Miura N; Sekikawa S; Furuta K; Lim CT; Shibahara T; Boku N; Kato K; Honda K
    Cancer Sci; 2019 Aug; 110(8):2590-2599. PubMed ID: 31169336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosome-based liquid biopsies in cancer: opportunities and challenges.
    Yu W; Hurley J; Roberts D; Chakrabortty SK; Enderle D; Noerholm M; Breakefield XO; Skog JK
    Ann Oncol; 2021 Apr; 32(4):466-477. PubMed ID: 33548389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid biopsies to occult brain metastasis.
    Rehman AU; Khan P; Maurya SK; Siddiqui JA; Santamaria-Barria JA; Batra SK; Nasser MW
    Mol Cancer; 2022 May; 21(1):113. PubMed ID: 35538484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced liquid biopsy technologies for circulating biomarker detection.
    Soda N; Rehm BHA; Sonar P; Nguyen NT; Shiddiky MJA
    J Mater Chem B; 2019 Nov; 7(43):6670-6704. PubMed ID: 31646316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond blood: Advancing the frontiers of liquid biopsy in oncology and personalized medicine.
    Bao Y; Zhang D; Guo H; Ma W
    Cancer Sci; 2024 Apr; 115(4):1060-1072. PubMed ID: 38308498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsy in ovarian cancer.
    Giannopoulou L; Lianidou ES
    Adv Clin Chem; 2020; 97():13-71. PubMed ID: 32448432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Utility of Combined Circulating Tumor Cell and Circulating Tumor DNA Assays for Diagnosis of Primary Lung Cancer.
    Moon SM; Kim JH; Kim SK; Kim S; Kwon HJ; Bae JS; Lee S; Lee HS; Choi MY; Jeon BH; Jeong BH; Lee K; Kim HK; Kim J; Um SW
    Anticancer Res; 2020 Jun; 40(6):3435-3444. PubMed ID: 32487642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Fast and Furious Liquid Biopsy Assay to Monitor Targeted Therapy Resistance.
    Nicolazzo C; Gazzaniga P
    Methods Mol Biol; 2022; 2535():93-104. PubMed ID: 35867225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential clinical utility of liquid biopsies in ovarian cancer.
    Zhu JW; Charkhchi P; Akbari MR
    Mol Cancer; 2022 May; 21(1):114. PubMed ID: 35545786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.
    Alix-Panabières C; Pantel K
    Cancer Discov; 2016 May; 6(5):479-91. PubMed ID: 26969689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid biopsy: a step forward towards precision medicine in urologic malignancies.
    Di Meo A; Bartlett J; Cheng Y; Pasic MD; Yousef GM
    Mol Cancer; 2017 Apr; 16(1):80. PubMed ID: 28410618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and achievements of liquid biopsy technologies employed in early breast cancer.
    Alba-Bernal A; Lavado-Valenzuela R; Domínguez-Recio ME; Jiménez-Rodriguez B; Queipo-Ortuño MI; Alba E; Comino-Méndez I
    EBioMedicine; 2020 Dec; 62():103100. PubMed ID: 33161226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.